Advanced search
Publication Cover
Free Radical Research Volume 36, 2002 - Issue 12
Submit an article Journal homepage
116
Views
103
CrossRef citations to date
0
Altmetric
Research Article

Oxidative Stress, Inflammation, and Diabetic Vasculopathies: The Role of Alpha Tocopherol Therapy

I. Jialal Laboratory for Atherosclerosis and Metabolic Research, Department of Pathology, UC Davis Medical Center, Sacramento, CA, USA
,
S. Devaraj Laboratory for Atherosclerosis and Metabolic Research, Department of Pathology, UC Davis Medical Center, Sacramento, CA, USA
&
S.K. Venugopal Laboratory for Atherosclerosis and Metabolic Research, Department of Pathology, UC Davis Medical Center, Sacramento, CA, USA
Pages 1331-1336 | Published online: 07 Jul 2009

  • Pyorala, K., Laakso, M. and Uusitupa, M. (1987) "Diabetes and atherosclerosis: an epidemiologic view", Diabetes 3, 463-524.
  • Bierman, E. (1992) "Atherogenesis in diabetes", Arterioscler. Thromb. 12, 647-656.
  • Witztum, J. and Steinberg, D. (1991) "Role of oxidized low density lipoprotein in atherogenesis", J. Clin. Investig. 88, 1785-1792.
  • Berliner, J. and Heinecke, J. (1992) "The role of oxidized lipoprotéine in atherogenesis", Free Radic. Biol. Med. 92, 127-143.
  • Devaraj, S. and Jialal, I. (1996) "Oxidized LDL and atherosclerosis", Int. J. Clin. Lab. Res. 26, 178-184.
  • Baynes, J. (1991) "Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes", Diabetes 40, 405-412.
  • Ceriello, A. (2000) "Oxidative stress and glycemic regulation", Metabolism 49, 27-30.
  • Rousselot, D.B., Bastard, J.P., Jaudon, M.C. and Delattre, J. (2000) "Consequences of the diabetic status on the oxidant/antioxidant balance", Diabetes Metab. 26, 163-176.
  • Kitahara, M., Eyre, H., Lynch, R., et al. (1980) "Metabolic activity of diabetic monocytes", Diabetes 29, 251-256.
  • Hill, H., Hogan, N., Rallison, M., et al. (1980) "Functional and metabolic abnormalities of diabetic monocytes", Adv. Exp. Med. Biol. 69, 621-627.
  • Vlassara, R (1997) "Recent progress in advanced glycation end products and diabetic complications", Diabetes 46, S19-S25.
  • Bucala, R., Makita, Z., Koschinski, T., et al. (1993) "Lipid advanced glycosylation: pathway for lipid oxidation in vivo", Proc. Natl Acad. Sci. USA 90, 6434-6438.
  • Oranje, W.A. and Wolffenbutte, B.H. (1992) "Lipid peroxidation and atherosclerosis in type II diabetes", J. Lab. Clin. Med. 134(1), 19-32.
  • Lamarche, B., Lemieux, L and Despres, J.P. (1999) "The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects", Diabetes Metab. 25, 199-211.
  • Bellomo, G., Maggi, E., PoIi, M., Agosta, F.G., Bollati, P. and Finardi, G. (1995) "Autoantibodies against Ox-LDL in NIDDM", Diabetes 44, 60-66.
  • Hsu, R.M., Devaraj, S. and Jialal, L (2002) "Autoantibodies to oxidized tow-density lipoprotein in patients with type 2 diabetes mellitus", Clin. Chim. Acta, Submitted for Publication.
  • Witztum, J.L., Mahoney, E.M., Branks, M.J., et al. (1982) "Nonenzymatic glycatton of LDL alters its biologic activity", Diabetes 31, 283-291.
  • Gopaul, N.K., Anggard, E.E., Mallet, A.I., Betteridge, D.J., Wolff, S.P. and Nourooz-Zadeh (1995) "Plasma 8-epi-PGF2alpha are elevated in individuals with NIDDM", FEBS Lett. 368, 225-229.
  • Davi, G., Ciabattoni, G., Consoli, A., Mezzetti, A., et al. (1999) "In vivo formation of 8-ep PGF2-alpha and platelet activation in diabetes mellitus-effect of improved metabolic control and vitamin E supplementation", Circulation 99, 224-229.
  • Devaraj, S., Hirany, S., Burke, R. and Jialal, I. (2002) "Divergence between LDL oxidative susceptibility and urinary Fz-isoprostanes as measures of oxidative stress in type 2 diabetes", Clin. Chem., In press.
  • Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowsk, J., Armstrong, D. and Nicotera, T. (1996) "Oxidative damage to DNA in diabetes mellitus", Lancet 347, 444-445.
  • Leinonen, J., Lehtimaki, T., Toyokuni, S., Okada, K., Tanaka, T., Hiai, H., Ochi, H., Laippala, P., Rantalaiho, V., Wirta, O., Pasternack, A. and Alho, R (1997) "New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus", FEBS Lett. 417, 150-152.
  • Ceriello, A., Mercuri, E, Quagliaro, L., Assaloni, R., Motz, E., Tonutti, L. and Taboga, C. (2001) "Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress", Diabetologia 44, 834-838.
  • Libby, P. and Hanson, G. (1991) "Biology of disease: involvement of the immune system in atherogenesis: current knowledge and unanswered questions", Lab. Investig. 64, 5-13.
  • Moreno, P.R., Murcia, A.M., Palacios, I.F., Leon, M.N., Bernardi, V.H., Fuster, V. and Fallon, J.T. (2000) "Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus", Circulation 102, 2180-2184.
  • Devaraj, S. and Jialal, L (2000) "Post-secretory modification, monocyte function and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha tocopherol supplementation", Circulation 102, 191-196.
  • Ridker, P. and Haughie, P. (1998) "Prospective studies of C-reactive protein as a risk factor for cardiovascular disease", J. Investig. Med. 46, 391-395.
  • Tracy, R. (1998) "Inflammation and cardiovascular disease, cart, horse or both", Circulation 97, 2000-2002.
  • Jialal, L and Devaraj, S. (2001) "Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker", Am. J. Clin. Pathol. 116(Suppl.), S108-S115.
  • Pickup, J., Mattock, M., Chusney, G., et al. (1997) "NIDDM as a disease of the innate immune system: association of acutephase reactants and interleukin-6 with metabolic syndrome X", Diabetologia 40, 1286-1292.
  • Ford, E. (1999) "Body mass index, diabetes, and C-reactive protein among US adults", Diabetes Care 22, 1971-1977.
  • Upritchard, J.E., Sutherland, W.H. and Mann, J.I. (2000) "Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes", Diabetes Care 23, 733-738.
  • Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D., O'Reilly, D.S., Packard, C.J. and Sattar, N. (2002) "C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study", Diabetes 51(5), 1596-1600.
  • Devaraj, S. and Jialal, L (2000) "AT supplementation decreases CRP and Mo IL-6 from DM-2", Free Radic. Biol. Med. 29, 790-792.
  • Desfaits, A., Serri, O. and Renier, G. (1998) "Normalization of plasma lipid peroxides, monocyte adhesion and TNF production in NIDDM patients after gliclazide treatment", Diabetes Care 21, 487-491.
  • Ross, R. (1995) "Cell biology of atherosclerosis", Ann. Rev. Physiol. 57, 791-804.
  • Kim, J., Berliner, J., Natarajan, R., et al. (1994) "Evidence that glucose increases monocyte binding to human aortic endothelial cells", Diabetes 43, 1103-1107.
  • Carantoni, M., Abbasi, F., Chu, L., et al. (1997) "Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM", Diabetes Care 20, 1462-1465.
  • Hoogerbrugge, N., Verkerk, A., Jacobs, M., et al. (1997) "Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM", Diabetes Care 3, 1122-1124
  • Hwang, S., Ballantyne, C.M., Sharrett, A.R., et al. (1997) "Circulating adhesion molecules VCAM-1-1, ICAM-1-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the atherosclerosis risk in communities (ARIC) study", Circulation 96, 4219-4225.
  • Rohde, L.E., Lee, R.T., Jamocochian, M., et al. (1998) "Circulating CAMs are correlated with ultrasound measurement of carotid atherosclerosis", Arterioscler. Thromb. Vasc. Biol. 18, 1765-1770.
  • Ridker, P.M., Hennekens, C.H., Roitman, J.B., et al. (1998) "Plasma concentration of soluble ICAM-1 and risks of future MI in apparently healthy men", Lancet 351, 88-92.
  • AIbertini, J.P., Valensi, P., Lormeau, B., Aurousseau, M.H., Fernere, F., Attali, J.R. and Gattegno, L. (1998) "Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment", Diabetes Care 21, 1008-1013.
  • Fasching, P., Waldhausl, W. and Wagner, O.F. (1996) "Elevated circulating adhesion molecules in NIDDM-potential mediators in diabetic macroangiopathy", Diabetologia 39, 1242-1244.
  • Matsumoto, K., Sera, Y., Abe, Y., Ueki, Y. and Miyake, S. (2001) "Serum concentrations of soluble vascular cell adhesion molecule-1 and e-selectin are elevated in insulin-resistant patients with type 2 diabetes", Diabetes Care 24, 1697-1698.
  • Mocco, J., Choudhri, T.F., Mack, W.J., Laufer, I., Lee, J., Kiss, S., Poisik, A., Quest, D.O., Solomon, R.A. and Connolly, E.S. (2001) "Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis", Neurosurgery 48, 718-721.
  • De Mattia, G., Bravi, M.C., Laurenti, O., Cassone-Faldetta, M., Proietti, A., De Luca, O., Armiento, A. and Ferri, C. (1998) "Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes", Diabetolqgia 41(11), 1392-1396.
  • Ridker, P.M., Buring, J.E., Shih, J., Matias, M. and Hennekens, C.H. (1998) "Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women", Circulation 98(8), 731-733.
  • Hofmaim, M.A., Schiekofer, S., Isermann, B., Kanitz, M., Henkels, M., Joswig, M., Treusch, A., Morcos, M., Weiss, T., Borcea, V., Abdel Khalek, A.K., Amiral, J., Tritschler, H., Ritz, E., Wahl, P., Ziegler, R., Bierhaus, A. and Nawroth, P.P. (1999) "Percheral blood mononudear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB", Diabetologia 42(2), 222-232.
  • Devaraj, S., Cabo Chan, A.V. and Jialal, I. (2002) "Alpha tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients", Diabetes Care, In press.
  • Venugopal, SJC, Devaraj, S., Yang, T.T.C. and Jialal, I. (2002) "Alpha tocopherol decreases Superoxide anion release in THP-1 cells under hyperglycemic conditions through inhibition of PKC/a", Diabetes 2002, In press.
  • Bursell, S.E., Clemont, A.C., Aiello, L.P., Aiello, L., Scholossman, D.K., Feener, E.P., Laffel, L. and King, G.L. (1999) "High dose AT supplementation normalizes retinal blood flow and creatinine clearance in patients with type I diabetes", Diabetes Care 22, 1245-1251.
  • Gaede, P., Poulsen, RE., Parving, H.H. and Pedersen, O. (2001) "Double blind randomized study of the effect of combined treatment with vitamin C and E on albuminuria in T2DM", Diabetes Med. 18, 756-760.
  • Paolisso, G., Tagliarnonte, M.R., Barbieri, M., Zito, G.A., Gambardella, A., Varricchio, G., Ragno, E. and Varricchio, M. (2000) "Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients", J. Clin. Endocrinol. Metab. 85, 109-115.
  • Gazis, A., White, D.J., Page, S.R. and Cockcroft, J.R. (1999) "Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitus", Diabetes Med. 16, 304-311.
  • Boaz, M., Sinetana, S., Weinstein, T., Matas, Z., Gafter, U., et al. (2000) "Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo controlled trial", Lancet 356, 1213-1218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.